Autoimmunity BioSolutions

Healthcare & Life Sciences

Recent Finacing

Seed

Recent Raise

$2M

Autoimmunity BioSolutions develops next-generation immuno-corrective therapies targeting genetically-defined subpopulations of patients with autoimmune diseases.

Total Funding

$2M

Headquarters

Houston, USA

Founded

N/A

Website

abstherapeutics.com

Focus Areas

Biotechnology

Immuno-corrective therapies

Autoimmune diseases

Genetically-defined subpopulation

Monoclonal antibodies

sIL7R

Investors